y 27632 has been researched along with pyrazines in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (pyrazines) | Trials (pyrazines) | Recent Studies (post-2010) (pyrazines) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 12,165 | 1,373 | 5,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishima, Y; Ishida, Y; Ito, S; Kowata, S; Murai, K; Shimoyama, T; Yashima-Abo, A | 1 |
| Chen, J; Chen, Y; Fan, Y; Gao, C; Li, W; Liu, D; Pan, S; Wang, H | 1 |
2 other study(ies) available for y 27632 and pyrazines
| Article | Year |
|---|---|
Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
Topics: Amides; Animals; Antineoplastic Agents; Blood Platelets; Bone Marrow; Boronic Acids; Bortezomib; Colony-Forming Units Assay; Disease Models, Animal; Male; Megakaryocyte Progenitor Cells; Megakaryocytes; Mice; Multiple Myeloma; Platelet Count; Pyrazines; Pyridines; rho-Associated Kinases; Thrombocytopenia; Thrombopoiesis; Thrombopoietin | 2014 |
Tetramethylpyrazine alleviates LPS-induced inflammatory injury in HUVECs by inhibiting Rho/ROCK pathway.
Topics: Acute Lung Injury; Amides; Apoptosis; Cell Survival; Cell-Derived Microparticles; Cytokines; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipopolysaccharides; Platelet Endothelial Cell Adhesion Molecule-1; Protective Agents; Pyrazines; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases | 2019 |